Clinical Trials Browser

INDUSTRY × Has results × Fractures, Bone × Clear all

Bone Neoplasms, Fractures, Bone

NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Phase 3 Completed

2,049 enrolled 16 charts

Breast

Breast Neoplasms, Fractures, Bone

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase 3 Completed

1,718 enrolled 22 charts

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT01343693 2020-01-06

MaxAn

Completed

119 enrolled 12 charts

Congenital Abnormalities, Neoplasms, Fractures, Bone

NCT00321620 2018-08-29

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Phase 3 Completed

1,904 enrolled 15 charts

Fractures, Bone

NCT01920568 2017-01-16

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Phase 3 Completed

487 enrolled 13 charts

Fractures, Bone

Clinical Trials

EPIBONE

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

MaxAn

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors